van Ness W Denman

Avg. Two Year Performance

No purchase track record
(1%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(12%)(12%)(1%)(< 1%)(1%)
Sale Success Rate2 of 42 of 40 of 41 of 41 of 4

XOMA Ltd.

Drugs » Biotechnology

Director:

Holdings: 15.64K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--